EP 1230264 A1 20020814 - THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES WITH MUTANT FORMS OF MYELOID PROGENITOR INHIBITORY FACTOR-2 (MPIF-2)
Title (en)
THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES WITH MUTANT FORMS OF MYELOID PROGENITOR INHIBITORY FACTOR-2 (MPIF-2)
Title (de)
THERAPEUTISCHE ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON KRANKHEITSZUSTÄNDEN MIT MUTANDEN DES MYELOIDEN VORLÄUFER-HEMMENDEN FAKTOR 2 (MPIF-2)
Title (fr)
COMPOSITIONS THERAPEUTIQUES ET TECHNIQUES DE TRAITEMENT D'ETATS PATHOLOGIQUES AVEC DES FORMES MUTANTES DU FACTEUR-2 INHIBITEUR DES PRECURSEURS MYELOIDES (MPIF-2)
Publication
Application
Priority
- US 0029351 W 20001025
- US 16140099 P 19991025
Abstract (en)
[origin: WO0130828A1] Human chemokine beta -6 agonist and antagonist polypeptides and DNA encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques are disclosed. The chemokine beta -6 antagonists of the present invention may be employed to treat rheumatoid arthritis, lung inflammation, allergy, asthma , infectious diseases and to prevent inflammation and atherosclerosis. The chemokine beta -6 agonists and antagonists may be employed to myeloprotect patients undergoing therapy such as chemotherapy or radiation therapy.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 31/7105 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 19/08 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 43/00 (2006.01); C07K 14/52 (2006.01); C12N 5/10 (2006.01)
CPC (source: EP)
A61P 19/08 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 43/00 (2017.12); C07K 14/523 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 0130828A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0130828 A1 20010503; AU 1342201 A 20010508; CA 2388942 A1 20010503; EP 1230264 A1 20020814; JP 2003528815 A 20030930
DOCDB simple family (application)
US 0029351 W 20001025; AU 1342201 A 20001025; CA 2388942 A 20001025; EP 00975359 A 20001025; JP 2001533825 A 20001025